$CPT

Evercore ISI Reaffirms Their Hold Rating on Camden Property (CPT)

Evercore ISI's Steve Sakwa maintained a Hold rating on Camden Property (CPT) with a $114 price target. Camden also has a Hold from Wells Fargo and a Buy from Bank of America. Q2 revenue was $395.5M, down slightly from last year's $396.51M, with net profit at $18.79M, significantly lower than last year's $80.67M.

Original reporting
Published Sep 15, 2026, 12:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 1:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Evercore ISI Reaffirms Their Hold Rating on Camden Property (CPT) — source image
Decision brief

The 30-second read

$CPTNeutralLow
01

Why it matters

Limited immediate price effect; investors may monitor for future guidance changes.

02

Market read

Minor relevance; reinforces existing market view on CPT.

03

What to watch

Upcoming lease renewals and rent growth could improve outlook.

Relevance 4/10Novelty 2/10Timing: none

Background

Analyst rating updates are common after earnings releases; this one repeats prior guidance.

Company-level read

Ticker impact

$CPTNeutralMedium confidence
Context

Evercore ISI reaffirmed Hold rating on Camden Property with a $114 price target and cited its latest earnings figures.

Expected impact

Limited movement unless rating changes.

Evidence & confidence

Hold rating with unchanged target provides little new catalyst; investors may wait for further guidance.

Market effects

Reinforces neutral stance on REIT sector for the day.

Minimal impact on US REIT market.

Low

Counterpoint

Potential upside if future earnings beat expectations.

Key entities

  • Camden Property Trust

    US-listed REIT (ticker CPT) focused on multifamily housing.

  • Evercore ISI

    Equity research provider issuing the Hold rating.

Related articles

$SRRKMed

SRRK Maintained by Evercore ISI Group -- Price Target Raised to

Evercore ISI Group analyst Cory Kasimov maintained an 'Outperform' rating on Scholar Rock Holding Corp (SRRK) and raised the price target from $65.00 to $72.00, a 10.77% increase. SRRK's current price is $47.34 with a market cap of $5.77 billion. The company's GF Score™ is 29/100, indicating room for improvement in financial metrics. Insider activity shows $923,107 in sales over the last three months. The company focuses on biotechnology, developing therapies for rare neuromuscular diseases.

$CAGMed

CAG Maintained by Evercore ISI Group -- Price Target Lowered to

Evercore ISI Group maintained an In-Line rating for Conagra Brands (CAG) but lowered its price target from $13.00 to $12.50, a 3.85% decrease. GuruFocus values CAG at $24.66, suggesting a 40.8% undervaluation, but warns of a potential value trap. The company has a GF Score of 58/100, indicating moderate performance. 11 gurus hold CAG, with 9 increasing their positions.